PExA

0.23 SEK

-7.79%

Less than 1K followers

PEXA B

Spotlight Stock Market

Medical Equipment & Services

Health Care

-7.79 %
-15.73 %
+13.07 %
+3.21 %
-29.69 %
+12.89 %
-42.48 %
-81.24 %
-89.24 %

PExA offers a patented, non-invasive technology to collect biomarkers from the small airways of the lung via exhaled air. The method is used globally by universities, hospitals, pharmaceutical companies, CROs and government agencies in the US and Europe, among others – in research on asthma, COPD, lung cancer, occupational exposure and pharmacokinetics. The company's goal is to enable earlier diagnosis and screening of lung diseases. PExA was founded in 2014 and is headquartered in Gothenburg.

Read more
Market cap
27.93M SEK
Turnover
48.97K SEK
Revenue
477.68K
EBIT %
-1,322.21 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
28.5
2026

General meeting '26

28.8
2026

Interim report Q2'26

6.11
2026

Interim report Q3'26